Leo Santamarina, MD
Ophthalmology · Sellersville, PANPI 1659339646
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,187 of the $1,384 with a category attached, or 85.7%. It is spread thinly across 19 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $424, 2.6 times the $163 reported in 2019. That places this record below the midpoint for ophthalmology clinicians in PA, where the typical reported total is $1,202.
Across 56 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$309
- AbbVie$186
- Regeneron Healthcare Solutions, Inc.$153
- Cardinal Health 110 LLC$150
- Astellas Pharma US Inc$97
- Novartis$95
- plus $394 from 13 others
What the payments were for
- Consulting fees$15011%
- Food & beverage$1,18786%
- Education$282%
- Gifts$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 19 | $309 |
| AbbVie(2 entities) | 4 | $186 |
| Regeneron Healthcare Solutions, Inc. | 2 | $153 |
| Cardinal Health 110 LLC | 1 | $150 |
| Astellas Pharma US Inc | 4 | $97 |
| Novartis | 6 | $95 |
| Kala Pharmaceuticals, Inc. | 4 | $71 |
| ANI Pharmaceuticals, Inc. | 2 | $54 |
| Alcon | 2 | $43 |
| Tarsus Pharmaceuticals, Inc. | 1 | $35 |
| Amgen | 2 | $34 |
| Biotissue Holdings Inc. | 1 | $30 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $29 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $15 |
| Apellis Pharmaceuticals, Inc. | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Thea Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,384 in reported general payments places this provider in the 50th percentile of 920 ophthalmology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclosporine | 14 | $8,034 |
| Difluprednate | 29 | $1,846 |
| Prednisolone Acetate | 12 | $1,025 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 44 | $615 |
| Latanoprost | 22 | $193 |
| Timolol Maleate | 16 | $115 |
| Brimonidine Tartrate | 14 | $57 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Sellersville
- Julia HallerPhiladelphia$1.5M
- Francis MahPittsburgh$1.1M
- Brandon AyresBala Cynwyd$929K
- David AlmeidaErie$734K
- Carl RegilloPlymouth Meeting$721K
- Robert NoeckerPittsburgh$632K
- Beeran MeghparaPhiladelphia$496K
- Michael KlufasPlymouth Meeting$393K
- Jonathan MyersPhiladelphia$359K
- Mark BlecherPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.